Cargando…

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

BACKGROUND AND OBJECTIVES: Relapsing-remitting multiple sclerosis (RRMS), aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) may have overlapping clinical features. There is an unmet need for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortese, Rosa, Prados Carrasco, Ferran, Tur, Carmen, Bianchi, Alessia, Brownlee, Wallace, De Angelis, Floriana, De La Paz, Isabel, Grussu, Francesco, Haider, Lukas, Jacob, Anu, Kanber, Baris, Magnollay, Lise, Nicholas, Richard S., Trip, Anand, Yiannakas, Marios, Toosy, Ahmed T., Hacohen, Yael, Barkhof, Frederik, Ciccarelli, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869760/ https://www.ncbi.nlm.nih.gov/pubmed/36192175 http://dx.doi.org/10.1212/WNL.0000000000201465

Ejemplares similares

Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event
por: Collorone, Sara, et al.
Publicado: (2021)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

Patterns of inflammation, microstructural alterations, and sodium accumulation define multiple sclerosis subtypes after 15 years from onset
por: Ricciardi, Antonio, et al.
Publicado: (2023)

Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
por: Lana-Peixoto, Marco A., et al.
Publicado: (2019)

Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders
por: García-Miranda, Pablo, et al.
Publicado: (2019)

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
por: Saadoun, Samira, et al.
Publicado: (2014)

Visual Function and Brief Cognitive Assessment for Multiple Sclerosis in Optic Neuritis Clinically Isolated Syndrome Patients
por: Collorone, Sara, et al.
Publicado: (2022)

Comparison of Neurite Orientation Dispersion and Density Imaging and Two-Compartment Spherical Mean Technique Parameter Maps in Multiple Sclerosis
por: Johnson, Daniel, et al.
Publicado: (2021)

Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report
por: Zhang, Chenyang, et al.
Publicado: (2021)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature
por: Spiezia, Antonio Luca, et al.
Publicado: (2022)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang, Ting-Ting, et al.
Publicado: (2016)

High-dimensional detection of imaging response to treatment in multiple sclerosis
por: Kanber, Baris, et al.
Publicado: (2019)

Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis
por: Kanber, Baris, et al.
Publicado: (2019)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)

Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome
por: Sahi, Nitin, et al.
Publicado: (2023)

Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique
por: Tur, Carmen, et al.
Publicado: (2021)

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding
por: Palazzo, Claudia, et al.
Publicado: (2019)

Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity
por: Pisani, Francesco, et al.
Publicado: (2013)

Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders
por: Motamedi, Seyedamirhosein, et al.
Publicado: (2020)

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio
por: Boonsuth, Ratthaporn, et al.
Publicado: (2021)

Cortical involvement determines impairment 30 years after a clinically isolated syndrome
por: Haider, Lukas, et al.
Publicado: (2021)

Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population
por: Mao, Zhifeng, et al.
Publicado: (2015)

The Neuroepithelium Disruption Could Generate Autoantibodies against AQP4 and Cause Neuromyelitis Optica and Hydrocephalus
por: Castañeyra-Ruiz, Leandro, et al.
Publicado: (2014)

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
por: Palace, Jacqueline, et al.
Publicado: (2019)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
por: Duan, Tianjiao, et al.
Publicado: (2018)

Mirror-Image Lesions in Sequential Relapses of AQP4-Positive Neuromyelitis Optica Spectrum Disorder
por: Muir, Ryan T., et al.
Publicado: (2020)

Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer—A case series
por: Duan, Yinghui, et al.
Publicado: (2022)

Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD)
por: Gernert, Jonathan A., et al.
Publicado: (2022)

Sarcoidosis and neuromyelitis optica in a patient with optic neuritis – a case report
por: Foster, Michael A., et al.
Publicado: (2021)

Modeling MOG Antibody–Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations
por: Remlinger, Jana, et al.
Publicado: (2023)

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
por: Clarke, Laura, et al.
Publicado: (2021)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: an exploratory, observational study
por: Wingrove, Jed, et al.
Publicado: (2023)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4
por: Pandit, Lekha, et al.
Publicado: (2020)

Serum antinuclear antibodies associate with worse prognosis in AQP4‐positive neuromyelitis optica spectrum disorder
por: Fan, Rong, et al.
Publicado: (2020)

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
por: dos Passos, Giordani Rodrigues, et al.
Publicado: (2018)

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders
por: Ringelstein, Marius, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l2dc2d18hpf01gtvtibo5a1cpo